| 李锐,李忻.基于精细化信息化的重点监控药品品种管理模式的探索与实践[J].中国药事,2022,36(10):1182-1189 |
| 基于精细化信息化的重点监控药品品种管理模式的探索与实践 |
| Exploration and Practice of Management Mode of Key Monitored Drug Varieties Based on Refi ned Informatization |
| |
| DOI：10.16153/j.1002-7777.2022.10.010 |
| 中文关键词: 精细化 信息化 重点监控药品品种 合理用药 药事管理 |
| 英文关键词: refi nement informationization key monitored drug varieties rational use pharmacy management |
| 基金项目:医院药品综合性评价体系建立及应用 [(2019)科技字(1871)号] |
|
| 摘要点击次数: 799 |
| 全文下载次数: 394 |
| 中文摘要: |
| 目的：为加强临床合理用药管理，规范临床用药行为，控制医药费用不合理增长。方法：完善组织架构，通过制定医院重点监控药品品种管理制度，编制医院重点监控药品品种目录，搭建“合理用药防控预警体系”，使用“ATC/DDDs系统”工具为临床药物选择提供更科学的参考意见等措施，对比管控前后的重点监控药品品种销售金额及占比、门诊及住院次均药费、药占比等药事管理指标，评价其实践效果。结果：重点监控品种的用药合理性有了明显提高，尤其是适应症和联合用药方面的合理率提高更为显著。重点监控药品品种销售金额由2019年22443.07万元降至2021年6857.18万元，销售占比由 2019年19.18%下降至2021年7.06%；门诊次均药费由2019年105.13元降至2021年74.57元，住院次均药费由2019年6669.61元降至2021年5310.09元；药占比由2019年28.7%下降至2021年20.76%。结论：精细化信息化管理模式有效降低重点监控品种销售金额及占比、门诊及住院次均药品费用、药占比，促进了重点监控药品品种的合理使用，极大地提高了我院的合理用药水平及医院管理水平。 |
| 英文摘要: |
| Objective: To strengthen the management of clinical rational drug use, standardize clinical drug use behavior and control the unreasonable increase of medical expenses. Methods: The organizational structure was improved. Measures were taken to provide more scientifi c references for clinical drug selection by formulating the management system of key monitored drug varieties of the hospital, compiling the catalog of key monitored drug varieties of the hospital, establishing the "rational drug use prevention and early warning system" and using the "ATC/DDDs system" tools. The sales amount and proportion of key monitored drug varieties before and after management and control, the average drug cost of outpatient and inpatient times, drug proportion and other drug management indicators were compared to evaluate its practical eff ect. Results: The rationality of drug use of key monitored drug varieties has been signifi cantly improved, especially the rationality rate of indications and drug interaction signifi cantly improved. The sales amount of key monitored drug varieties decreased from 224,430,700 yuan in 2019 to 68.5718 million yuan in 2021, and the sales proportion decreased from 19.18% in 2019 to 7.06% in 2021; the average cost of outpatient medicine decreased from 105.13 yuan in 2019 to 74.57 yuan in 2021, and the average cost of inpatient medicine decreased from 6669.61 yuan in 2019 to 5310.09 yuan in 2021; the proportion of drugs decreased from 28.7% in 2019 to 20.76% in 2021. Conclusion: The refi ned information management mode has eff ectively reduced the sales amount and proportion of key monitored drug varieties, the average drug cost and proportion of outpatient and inpatient times, promoted the rational use of key monitored drug varieties, and greatly improved the rational drug use level and hospital management level of our hospital. |
|
查看全文
查看/发表评论 下载PDF阅读器 |
| 关闭 |